{"transactions":[{"id":1341292,"issuer":{"id":5502,"kind":"organization","name":"Editas Medicine, Inc.","symbol":"EDIT"},"owners":[{"id":85396,"kind":"person","name":"Mei Baisong","position":1,"cik":"0001938499","reported_name":"Mei Baisong","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CHIEF MEDICAL OFFICER"}}],"security":"Common Stock","published_at":"2024-12-05T21:37:25.000Z","date":"2024-12-03","kind":"sale","planned":true,"acquired":false,"shares":541,"price":2.0772,"value":1123.7652,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Sale was effected pursuant to a durable automatic sales instruction plan adopted by the Reporting Person on June 14, 2022, and represents the sale of shares by the Issuer necessary to meet tax withholding obligations as a result of vesting in restricted stock units on December 2, 2024. The sale does not represent a discretionary trade by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $2.0507  to $2.0783. The price reported above reflects the weighted average purchase price. The Reporting Person hereby undertakes to provide upon request, to the SEC staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":133354,"source":{"system":"sec-edgar","filing":"0001650664-24-000124","document":"wk-form4_1733434638.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1650664/000165066424000124/wk-form4_1733434638.xml","form_type":"4"}},{"id":1412509,"issuer":{"id":5502,"kind":"organization","name":"Editas Medicine, Inc.","symbol":"EDIT"},"owners":[{"id":85396,"kind":"person","name":"Mei Baisong","position":1,"cik":"0001938499","reported_name":"Mei Baisong","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CHIEF MEDICAL OFFICER"}}],"security":"Common Stock","published_at":"2024-09-06T20:20:37.000Z","date":"2024-09-04","kind":"sale","planned":true,"acquired":false,"shares":518,"price":3.4247,"value":1773.9946,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Sale was effected pursuant to a durable automatic sales instruction plan adopted by the Reporting Person on June 14, 2022, and represents the sale of shares by the Issuer necessary to meet tax withholding obligations as a result of vesting in restricted stock units on September 2, 2024. The sale does not represent a discretionary trade by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $3.4246 to $3.4501. The price reported above reflects the weighted average purchase price. The Reporting Person hereby undertakes to provide upon request, to the SEC staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":133895,"source":{"system":"sec-edgar","filing":"0001650664-24-000105","document":"wk-form4_1725654028.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1650664/000165066424000105/wk-form4_1725654028.xml","form_type":"4"}},{"id":1450308,"issuer":{"id":5502,"kind":"organization","name":"Editas Medicine, Inc.","symbol":"EDIT"},"owners":[{"id":85396,"kind":"person","name":"Mei Baisong","position":1,"cik":"0001938499","reported_name":"Mei Baisong","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CHIEF MEDICAL OFFICER"}}],"security":"Common Stock","published_at":"2024-07-22T21:01:17.000Z","date":"2024-07-19","kind":"sale","planned":true,"acquired":false,"shares":6619,"price":5.2056,"value":34455.8664,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Sale was effected pursuant to a durable automatic sales instruction plan adopted by the Reporting Person on June 14, 2022, and represents the sale of shares by the Issuer necessary to meet tax withholding obligations as a result of vesting in restricted stock units on July 18, 2024. The sale does not represent a discretionary trade by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $5.1650 to $5.2058. The price reported above reflects the weighted average purchase price. The Reporting Person hereby undertakes to provide upon request, to the SEC staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":134413,"source":{"system":"sec-edgar","filing":"0001650664-24-000087","document":"wk-form4_1721682068.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1650664/000165066424000087/wk-form4_1721682068.xml","form_type":"4"}},{"id":1488031,"issuer":{"id":5502,"kind":"organization","name":"Editas Medicine, Inc.","symbol":"EDIT"},"owners":[{"id":85396,"kind":"person","name":"Mei Baisong","position":1,"cik":"0001938499","reported_name":"Mei Baisong","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CHIEF MEDICAL OFFICER"}}],"security":"Common Stock","published_at":"2024-06-06T20:16:13.000Z","date":"2024-06-04","kind":"sale","planned":true,"acquired":false,"shares":511,"price":5.4956,"value":2808.2516,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Sale was effected pursuant to a durable automatic sales instruction plan adopted by the Reporting Person on  June 14, 2022, and represents the sale of shares by the Issuer necessary to meet tax withholding obligations as a result of vesting in restricted stock units on June 2, 2024. The sale does not represent a discretionary trade by the Reporting Person."}],"balance_after":141032,"source":{"system":"sec-edgar","filing":"0001650664-24-000075","document":"wk-form4_1717704962.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1650664/000165066424000075/wk-form4_1717704962.xml","form_type":"4"}},{"id":1593949,"issuer":{"id":5502,"kind":"organization","name":"Editas Medicine, Inc.","symbol":"EDIT"},"owners":[{"id":85396,"kind":"person","name":"Mei Baisong","position":1,"cik":"0001938499","reported_name":"Mei Baisong","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, CHIEF MEDICAL OFFICER"}}],"security":"Stock Option (right to  buy)","published_at":"2024-03-06T00:54:42.000Z","date":"2024-03-02","kind":"grant","planned":true,"acquired":true,"shares":152800,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"This option was granted on March 2, 2024 and is scheduled to vest over four years in equal monthly installments beginning on  April  2, 2024 through March 2, 2028."}],"balance_after":152800,"derivative":{"exercise_price":10.53,"expiration_date":"2034-03-01","underlying":"Common Stock","underlying_shares":152800},"source":{"system":"sec-edgar","filing":"0001650664-24-000013","document":"wk-form4_1709686469.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1650664/000165066424000013/wk-form4_1709686469.xml","form_type":"4"}},{"id":1593948,"issuer":{"id":5502,"kind":"organization","name":"Editas Medicine, Inc.","symbol":"EDIT"},"owners":[{"id":85396,"kind":"person","name":"Mei Baisong","position":1,"cik":"0001938499","reported_name":"Mei Baisong","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, CHIEF MEDICAL OFFICER"}}],"security":"Common Stock","published_at":"2024-03-06T00:54:42.000Z","date":"2024-03-04","kind":"sale","planned":true,"acquired":false,"shares":20327,"price":9.4173,"value":191425.4571,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F4","text":"Sale was effected pursuant to a durable automatic sales instruction plan adopted by the Reporting Person on June 14, 2022 and represents the sale of shares by the Issuer necessary to meet tax withholding obligations as a result of vesting in restricted stock units on March 2, 2024. The sale does not represent a discretionary trade by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"This transaction was executed in multiple trades at prices ranging from $9.1036 to $9.4298. The price reported above reflects the weighted average purchase price. The Reporting Person hereby undertakes to provide upon request, to the SEC staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":141543,"source":{"system":"sec-edgar","filing":"0001650664-24-000013","document":"wk-form4_1709686469.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1650664/000165066424000013/wk-form4_1709686469.xml","form_type":"4"}},{"id":1593947,"issuer":{"id":5502,"kind":"organization","name":"Editas Medicine, Inc.","symbol":"EDIT"},"owners":[{"id":85396,"kind":"person","name":"Mei Baisong","position":1,"cik":"0001938499","reported_name":"Mei Baisong","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, CHIEF MEDICAL OFFICER"}}],"security":"Common Stock","published_at":"2024-03-06T00:54:42.000Z","date":"2024-03-02","kind":"grant","planned":true,"acquired":true,"shares":19457,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"Reflects the vesting, upon the achievement of a business development milestone, of a portion of a performance-based  restricted stock unit award  originally granted on July 18, 2022."}],"balance_after":161870,"source":{"system":"sec-edgar","filing":"0001650664-24-000013","document":"wk-form4_1709686469.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1650664/000165066424000013/wk-form4_1709686469.xml","form_type":"4"}},{"id":1593946,"issuer":{"id":5502,"kind":"organization","name":"Editas Medicine, Inc.","symbol":"EDIT"},"owners":[{"id":85396,"kind":"person","name":"Mei Baisong","position":1,"cik":"0001938499","reported_name":"Mei Baisong","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, CHIEF MEDICAL OFFICER"}}],"security":"Common Stock","published_at":"2024-03-06T00:54:42.000Z","date":"2024-03-02","kind":"grant","planned":true,"acquired":true,"shares":19458,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Reflects the vesting, upon the achievement of a specified research and development milestone, of a portion of a performance-based restricted stock unit award originally granted on July 18, 2022."}],"balance_after":142413,"source":{"system":"sec-edgar","filing":"0001650664-24-000013","document":"wk-form4_1709686469.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1650664/000165066424000013/wk-form4_1709686469.xml","form_type":"4"}},{"id":1593945,"issuer":{"id":5502,"kind":"organization","name":"Editas Medicine, Inc.","symbol":"EDIT"},"owners":[{"id":85396,"kind":"person","name":"Mei Baisong","position":1,"cik":"0001938499","reported_name":"Mei Baisong","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, CHIEF MEDICAL OFFICER"}}],"security":"Common Stock","published_at":"2024-03-06T00:54:42.000Z","date":"2024-03-02","kind":"grant","planned":true,"acquired":true,"shares":50900,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The common stock received by the Reporting Person was in connection with the grant of a restricted stock unit award to the Reporting Person, for no consideration, and which is scheduled to vest over four years with 25% of the units vesting on March 2, 2025 and the remaining 75% of the units scheduled to vest in equal quarterly installments thereafter through March 2, 2028."}],"balance_after":122955,"source":{"system":"sec-edgar","filing":"0001650664-24-000013","document":"wk-form4_1709686469.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1650664/000165066424000013/wk-form4_1709686469.xml","form_type":"4"}},{"id":1824653,"issuer":{"id":5502,"kind":"organization","name":"Editas Medicine, Inc.","symbol":"EDIT"},"owners":[{"id":85396,"kind":"person","name":"Mei Baisong","position":1,"cik":"0001938499","reported_name":"Mei Baisong","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, CHIEF MEDICAL OFFICER"}}],"security":"Common Stock","published_at":"2023-07-21T20:30:09.000Z","date":"2023-07-19","kind":"sale","planned":true,"acquired":false,"shares":4317,"price":8.8,"value":37989.6,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Sale was effected pursuant to a durable automatic sales instruction plan adopted by the Reporting Person on June 14, 2022 and represents the sale of shares by the Issuer necessary to meet tax withholding obligations as a result of vesting in restricted stock units on July 18, 2023. The sale does not represent a discretionary trade by the Reporting Person."}],"balance_after":72055,"source":{"system":"sec-edgar","filing":"0001415889-23-011382","document":"form4-07212023_040701.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1650664/000141588923011382/form4-07212023_040701.xml","form_type":"4"}},{"id":1968196,"issuer":{"id":5502,"kind":"organization","name":"Editas Medicine, Inc.","symbol":"EDIT"},"owners":[{"id":85396,"kind":"person","name":"Mei Baisong","position":1,"cik":"0001938499","reported_name":"Mei Baisong","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, CHIEF MEDICAL OFFICER"}}],"security":"Stock Option (right to buy)","published_at":"2023-03-06T21:30:14.000Z","date":"2023-03-02","kind":"grant","acquired":true,"shares":54000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option was granted on March 2, 2023 and is scheduled to vest over four years in equal monthly installments beginning on April 2, 2023 through March 2, 2027."}],"balance_after":54000,"derivative":{"exercise_price":8.72,"expiration_date":"2033-03-01","underlying":"Common Stock","underlying_shares":54000},"source":{"system":"sec-edgar","filing":"0001415889-23-004314","document":"form4-03062023_040307.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1650664/000141588923004314/form4-03062023_040307.xml","form_type":"4"}},{"id":1968195,"issuer":{"id":5502,"kind":"organization","name":"Editas Medicine, Inc.","symbol":"EDIT"},"owners":[{"id":85396,"kind":"person","name":"Mei Baisong","position":1,"cik":"0001938499","reported_name":"Mei Baisong","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, CHIEF MEDICAL OFFICER"}}],"security":"Common Stock","published_at":"2023-03-06T21:30:14.000Z","date":"2023-03-02","kind":"grant","acquired":true,"shares":18000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The common stock received by the Reporting Person was in connection with the grant of a restricted stock unit award to the Reporting Person, for no consideration, and which is scheduled to vest over four years with 25% of the units vesting on March 2, 2024 and the remaining 75% of the units scheduled to vest in equal quarterly installments thereafter\nthrough March 2, 2027."}],"balance_after":76372,"source":{"system":"sec-edgar","filing":"0001415889-23-004314","document":"form4-03062023_040307.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1650664/000141588923004314/form4-03062023_040307.xml","form_type":"4"}},{"id":2204407,"issuer":{"id":5502,"kind":"organization","name":"Editas Medicine, Inc.","symbol":"EDIT"},"owners":[{"id":85396,"kind":"person","name":"Mei Baisong","position":1,"cik":"0001938499","reported_name":"Mei Baisong","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, CHIEF MEDICAL OFFICER"}}],"security":"Stock Option (right to buy)","published_at":"2022-07-20T20:36:56.000Z","date":"2022-07-18","kind":"grant","acquired":true,"shares":171602,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option was granted on July 18, 2022 and is scheduled to vest over four years, with 25% of the shares to vest on July 18, 2023 and the remaining 75% of the shares scheduled to vest in equal monthly installments thereafter through July 18, 2026."}],"balance_after":171602,"derivative":{"exercise_price":14.99,"expiration_date":"2032-07-17","underlying":"Common Stock","underlying_shares":171602},"source":{"system":"sec-edgar","filing":"0001415889-22-007838","document":"form4-07202022_010742.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1650664/000141588922007838/form4-07202022_010742.xml","form_type":"4"}},{"id":2204406,"issuer":{"id":5502,"kind":"organization","name":"Editas Medicine, Inc.","symbol":"EDIT"},"owners":[{"id":85396,"kind":"person","name":"Mei Baisong","position":1,"cik":"0001938499","reported_name":"Mei Baisong","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, CHIEF MEDICAL OFFICER"}}],"security":"Common Stock","published_at":"2022-07-20T20:36:56.000Z","date":"2022-07-18","kind":"grant","acquired":true,"shares":58372,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The common stock received by the Reporting Person was in connection with the grant of a restricted stock unit award to the Reporting Person, for no consideration, and which is scheduled to vest over four years in equal yearly installments of one-fourth of the shares, with the first such installment to vest on July 18, 2023 continuing through July 18, 2026."}],"balance_after":58372,"source":{"system":"sec-edgar","filing":"0001415889-22-007838","document":"form4-07202022_010742.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1650664/000141588922007838/form4-07202022_010742.xml","form_type":"4"}}]}